Pnictogens in medicinal chemistry: evolution from erstwhile drugs to emerging layered photonic nanomedicine

Author:

Liu Chuang123ORCID,Shin Jinwoo456ORCID,Son Subin456,Choe Youmi456,Farokhzad Nika783,Tang Zhongmin123ORCID,Xiao Yufen123,Kong Na123,Xie Tian910111210,Kim Jong Seung456ORCID,Tao Wei123ORCID

Affiliation:

1. Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School

2. Boston

3. USA

4. Department of Chemistry, Korea University

5. Seoul

6. Korea

7. Milton Academy

8. Milton

9. College of Pharmacy, School of Medicine, Hangzhou Normal University

10. Hangzhou

11. China

12. Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University

Abstract

This review highlights pnictogen-based therapeutic agents, from ancient clinical drugs to recently emerging layered photonic nanomedicines. In addition, an update on recent biosafety studies of layered pnictogen is also provided.

Funder

National Research Foundation of Korea

National Natural Science Foundation of China

METAvivor

American Heart Association

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3